BIOMAR A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.4% 0.0% 0.4% 1.1% 0.5%  
Credit score (0-100)  64 0 99 83 99  
Credit rating  BBB N/A AAA A AAA  
Credit limit (mDKK)  0.0 26.0 26.3 4.5 19.5  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2019
2019/12
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  1,304 1,215 1,270 1,257 1,308  
Gross profit  107 117 175 121 155  
EBITDA  88.1 89.6 62.7 12.7 47.4  
EBIT  88.1 89.6 62.7 12.7 47.4  
Pre-tax profit (PTP)  90.6 88.2 90.6 -2.5 49.3  
Net earnings  90.6 88.2 76.5 -5.9 41.3  
Pre-tax profit without non-rec. items  88.1 89.6 90.6 -2.5 49.3  

 
See the entire income statement

Balance sheet (mDKK) 
2019
2019/12
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 200 188 171  
Shareholders equity total  203 196 201 108 145  
Interest-bearing liabilities  0.0 0.0 233 336 259  
Balance sheet total (assets)  556 503 595 593 555  

Net Debt  0.0 0.0 233 336 259  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  1,304 1,215 1,270 1,257 1,308  
Net sales growth  9.8% -6.8% 4.5% -1.0% 4.0%  
Gross profit  107 117 175 121 155  
Gross profit growth  -8.9% 9.6% 49.3% -30.9% 27.8%  
Employees  0 0 124 122 120  
Employee growth %  0.0% 0.0% 0.0% -1.6% -1.6%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  556 503 595 593 555  
Balance sheet change%  48.6% -9.5% 18.1% -0.2% -6.4%  
Added value  88.1 89.6 62.7 12.7 47.4  
Added value %  6.8% 7.4% 4.9% 1.0% 3.6%  
Investments  0 0 200 -11 -18  

Net sales trend  1.0 -1.0 1.0 -1.0 1.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  6.8% 7.4% 4.9% 1.0% 3.6%  
EBIT %  6.8% 7.4% 4.9% 1.0% 3.6%  
EBIT to gross profit (%)  82.4% 76.4% 35.8% 10.5% 30.7%  
Net Earnings %  7.0% 7.3% 6.0% -0.5% 3.2%  
Profit before depreciation and extraordinary items %  7.0% 7.3% 6.0% -0.5% 3.2%  
Pre tax profit less extraordinaries %  6.8% 7.4% 7.1% -0.2% 3.8%  
ROA %  18.9% 16.9% 16.8% 0.6% 10.7%  
ROI %  18.9% 16.9% 19.4% 0.8% 14.1%  
ROE %  46.2% 44.2% 38.6% -3.8% 32.6%  

Solidity 
2019
2019/12
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  100.0% 100.0% 33.8% 18.2% 26.2%  
Relative indebtedness %  0.0% 0.0% 30.1% 37.7% 30.4%  
Relative net indebtedness %  0.0% 0.0% 30.0% 37.7% 30.4%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 371.1% 2,646.7% 547.4%  
Gearing %  0.0% 0.0% 116.1% 312.0% 178.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 1.4% 2.1% 4.1%  

Liquidity 
2019
2019/12
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.5 0.3 0.4  
Current Ratio  0.0 0.0 0.8 0.7 0.9  
Cash and cash equivalent  0.0 0.0 0.7 0.1 0.2  

Capital use efficiency 
2019
2019/12
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 14.4 17.9 17.2  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 23.4% 26.6% 24.8%  
Net working capital  0.0 0.0 -84.9 -115.0 -50.2  
Net working capital %  0.0% 0.0% -6.7% -9.2% -3.8%  

Employee efficiency 
2019
2019/12
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 10 10 11  
Added value / employee  0 0 1 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 1 0 0  
EBIT / employee  0 0 1 0 0  
Net earnings / employee  0 0 1 -0 0